Meetings

  • Meeting 3: Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action Date: June 3, 2019 (1:00 PM Eastern)

    The NASEM Committee on Addressing Sickle Cell Disease: A Strategic Blueprint and Plan for Action will hold an open session to hear from experts in the SCD community on Monday, June 3, 2019.
  • Breaking Down Silos: The Convergence of Infectious Diseases and Noncommunicable Diseases – A Workshop Date: June 11, 2019 - June 12, 2019 (1:00 PM Eastern)

    This is a 1.5-day workshop that will explore the growing understanding of how microbes interact with and affect humans in multiple ways, ranging from affecting normal physiological functions to chronic diseases. The workshop will allow participants to gain a deeper understanding of how the distinction between infectious diseases and noncommunicable diseases is blurring and how this is extending to new approaches, such as the use of vaccination to treat certain cancers.
  • Health Literacy and Communication Strategies in Oncology: A Workshop Date: July 15, 2019 - July 16, 2019 (8:00 AM Eastern)

    Health literacy is the degree to which individuals can access, comprehend, and use information to make health care decisions. However, estimates suggest that more than one-third of the U.S. adult population has low health literacy. Inadequate health literacy can make it difficult for individuals to engage in healthy behaviors and navigate the health care system across the cancer care continuum. To consider opportunities to improve communication in cancer prevention and care, as well as to better support individuals with low health literacy, the Forum is collaborating with the Roundtable on Health Literacy to host a workshop on this topic.
  • Applying Big Data to Address the Social Determinants of Health in Oncology: A Workshop Date: October 28, 2019 - October 29, 2019 (8:00 AM Eastern)

    The collection and analysis of big data is expected to transform the field of cancer research and improve cancer care. Innovations in analytic methods, coupled with large-scale efforts to collect big data, are advancing progress in precision medicine initiatives and facilitating research on factors that influence cancer incidence and outcomes.